Results 41 to 50 of about 1,090 (156)
Sri Lanka Journal of Diabetes Endocrinology and Metabolism, 2016 Graves’ Orbitopathy (GO) is a localized entity of Graves’ disease, which is a challenging disease to treat. We describe 6 cases of moderate to severe GO who presented to our endocrine centre, with a mean age of 48.6 years and equal gender distribution ...
D. C. Kottahachchi +4 more
doaj +1 more source
Orbital decompression for thyroid eye disease: surgical treatment outcomes in endocrinological assessment [PDF]
, 2021 Introduction: Surgical orbital decompression involves removal of one or more of the orbital bony walls in order to gain space for overgrown muscles and adipose tissue, which results in a reduction in pressure on the eye.
Jastrzębska, Helena; Department of Endocrinology, Medical Centre of Postgraduate Education in Warsaw, Warsaw, 01-809, Poland +3 more
core +2 more sources
Acta Ophthalmologica, EarlyView.Abstract Background Quality of life (QoL) is a key outcome in Graves' orbitopathy (GO), but prior studies have reported overall QoL changes without evaluating whether improvements occur specifically in patients who achieve objective clinical response.
Gijsbert J. Hötte +8 more
wiley +1 more source
Transcriptomic and Neuroimaging Decoding of Brain‐Immune Crosstalk in Thyroid Eye Disease
Advanced Science, Volume 13, Issue 27, 13 May 2026.This study employed an imaging transcriptomics framework integrating resting‐state fMRI with Allen Human Brain Atlas transcriptomic data, coupled with peripheral blood RNA sequencing, to decode brain‐immune crosstalk in thyroid eye disease. Frontal, parietal, subcortical, and brainstem regions were identified as key neuroimmune‐ vulnerable regions ...
Haiyang Zhang +15 more
wiley +1 more source
International Symposium for Thyroid Eye Disease (June 2016, London)
Клиническая и экспериментальная тиреоидология, 2017 In June 2016, an International Symposium dedicated to the cutting edge research and achievements in Thyroid Eye Disease (TED) diagnosis and treatment was held in London. The symposium was organized by the International Thyroid Eye Disease (ITEDs). It was
Natalia Y. Sviridenko +2 more
doaj +1 more source
CNS Neuroscience &Therapeutics, Volume 32, Issue 2, February 2026.The diagnostic model combining orbital and intracranial MAP‐MRI parameters could significantly optimize diagnostic efficiency of dysthyroid optic neuropathy. Comprehensive MAP‐MRI parameters analysis of the entire visual pathway enables a deeper understanding of disease involvement, provides novel insights into the early accurate diagnosis and ...
Mengsha Zou +7 more
wiley +1 more source
Enfermedad de Graves y orbitopatía tiroidea en el embarazo
Revista Colombiana de Endocrinología, Diabetes y Metabolismo, 2023 Introducción: la orbitopatía tiroidea (OT) es una manifestación frecuente de la enfermedad de Graves. En el embarazo, la enfermedad de Graves no controlada representa un reto para el tratamiento por los riesgos que puede ocasionar a la madre y al feto.
Oscar David Lucero Pantoja +1 more
doaj +1 more source
Exploring tear fluid biomarkers and the ocular surface in thyroid eye disease
Acta Ophthalmologica, Volume 104, Issue 1, Page e28-e38, February 2026.Abstract Purpose To examine ocular surface changes and inflammatory tear fluid biomarkers in patients with thyroid eye disease (TED). Methods We included 106 Graves' disease (GD) patients (36 without TED, 32 with active and 38 with inactive TED) and 106 age‐ and sex‐matched healthy subjects for ophthalmological evaluation, including ocular surface ...
Mikael Thomassen Neset +13 more
wiley +1 more source
Advances in Public Health, Volume 2026, Issue 1, 2026.Purpose Thyroid eye disease (TED) is the most common orbital disorder in adults. Its initial clinical manifestations are heterogeneous and may influence early diagnosis and management. However, limited data exist on real‐world perspectives from oculoplastic surgeons who frequently manage patients with TED.
Shiqi Hui +4 more
wiley +1 more source
Glymphatic System Dysfunction in Thyroid‐Associated Ophthalmopathy: A Multimodal MRI Study
CNS Neuroscience &Therapeutics, Volume 31, Issue 11, November 2025.TAO patients exhibit impaired glymphatic function, with reduced DTI‐ALPS indices and gBOLD‐CSF coupling, but unchanged choroid plexus volume. These alterations correlate with neuropsychological symptoms and sleep disturbances. Restoring glymphatic activity may offer a therapeutic approach to enhance patient outcomes.
Lijie Zhang +4 more
wiley +1 more source